Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

International hypoglycaemia study group, and Campbell, Matthew (2017) Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care, 40 (1). pp. 155-157. ISSN 1935-5548

[img]
Preview
PDF
13136.pdf - Published Version
Available under License Creative Commons Attribution.

Download (317kB) | Preview

Search Google Scholar

Abstract

Position Statement

The International Hypoglycaemia Study Group recommends that the frequency of detection of a glucose concentration <3.0 mmol/l (<54 mg/dl), which it considers to be clinically significant biochemical hypoglycaemia, be included in reports of clinical trials of glucose-lowering drugs evaluated for the treatment of diabetes mellitus.

Item Type: Article
Divisions: Faculty of Health Sciences and Wellbeing
Depositing User: Matthew Campbell
Date Deposited: 01 Mar 2021 09:36
Last Modified: 01 Mar 2021 09:45
URI: http://sure.sunderland.ac.uk/id/eprint/13136
ORCID for Matthew Campbell: ORCID iD orcid.org/0000-0001-5883-5041

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year